LMIC Health Economics and Outcomes Research Excellence Award

Not a member? Click below to become an ISPOR member

About the Award

The ISPOR LMIC (Low- and Middle-Income Countries) Health Economics and Outcomes Research Excellence Award recognizes individuals with demonstrated outstanding research achievements in the area of health economics and outcomes research in LMICs (as defined by the World Bank).

Criteria:

Evidence of research excellence will be assessed by evaluating the nominee’s body of work in the fields of health economics and outcomes research. Applications should provide a summary of the significant research contributions of the nominee in the methods or applications of health economics or outcomes research in LMICs. If applicable, the applications should also include specific examples of the impact of the nominee’s work on healthcare decision making or health outcomes in LMICs.

Academicians, decision makers, industry professionals, economists, researchers and others who meet these criteria are eligible. ISPOR promotes the application of professionals newer to HEOR.

• It is strongly encouraged that the recipient be an ISPOR member in good standing for at least 2 consecutive years.

• Evidence of excellence to be assessed by evaluating the nominee's body of technical and scholarly work in the fields of health economics and outcomes research.

• The body of work may include research publications, technical reports and papers, books and book chapters, and other scholarly activities that establish the importance of the nominee's contributions. At least one paper should be published in a peer-reviewed journal indexed in MEDLINE or EMBASE.

• Academicians, decision makers, industry professionals, economists, researchers, and others who meet these criteria are eligible.

• Self-nominations are encouraged.

• A candidate may only be nominated for 1 major ISPOR award in a year.

• An individual may only receive this award once in a lifetime.

Nomination Process:

Nominators or those self-nominating must submit an application, a letter of recommendation by an ISPOR member indicating why the nominee should receive this award, and the nominee’s current curriculum vitae. Applications must be received by the deadline specified above.

Nature of the Award:

The recipient will receive the award at the Awards Ceremony at the ISPOR Conference. The recipient will receive the following:

A complimentary registration to the ISPOR Conference
Travel and Accommodation expenses to the ISPOR Conference, per the ISPOR Travel Reimbursement policy
A complimentary ISPOR membership for a year
An unrestricted grant of $5000 USD

Recipients of the LMIC Health Economics Outcomes Research Excellence Award

LMIC-Excellence--photo_Eman-Hammad-(preferred)

Professor of Health Economics and Clinical Pharmacy; University of Jordan; Amman, Jordan

2025 - Eman Hammad, PhD

Dr. Eman A. Hammad is Professor of Health Economics and Clinical Pharmacy at the University of Jordan-school of Pharmacy and the Vic Director of the Institute of Public Health at the University of Jordan.

Dr. Hammad’s research focuses on health economics and evidence-based policy, with particular contributions to hospital and health system costing and has directly informed national strategies on UHC, HTA institutionalization, and public cost containment strategies.

She co-developed Jordan’s first Master’s Program in Health Economics and Health Policy, advancing capacity building in HEOR for Jordan and other LMICs.

In addition to her academic leadership, Dr. Hammad serves as a local key Expert providing technical expertise supporting leading international aid organizations including the World Bank, WHO, USAID, and the European Union Delegation to inform policies and system strengthening initiatives.

She is the founder and leader of the Health Economics and Health Policy Research Group in Jordan, which advances interdisciplinary research, policy analysis and foster regional and international collaborations across LMICs.

Professor, Universidad of Cartagena, Cartagena, Colombia

2024 - Nelson Rafael Alvis-Guzman, MD, PhD

Dr Nelson Alvis-Guzman has been Professor and Director of the Health Economics Research Group (GIES, in Spanish) at the University of Cartagena, Colombia since 1997. The GIES was selected in 2010 as a center of excellence for the evaluation of new vaccines by the PAHO/WHO ProVac initiative, funded by the Bill and Melinda Gates Foundation.

Professor Nelson published one of the first cost-effectiveness analysis of vaccines in Colombia in 2005. With over 30 years of dedicated research, he has consolidated a career as a senior researcher with one of the highest Google Scholar H-indexes in public health, epidemiology and health economics in Colombia and the region (H-index = 93). He is also a member (senior collaborator) of the Global Burden of Disease network of the Institute of Health Metrics at the University of Washington. In this network, he has co-authored many studies on the burden of preventable and noncommunicable diseases.

Vice Head of Department of Health Economics, Hanoi Medical University, Hanoi, Vietnam

2023 - Bach Xuan Tran, PhD

Dr. Bach Tran, Vice Head of Health Economics at Hanoi Medical University and Adjunct Professor at Johns Hopkins University Bloomberg School of Public Health, specializes in decision analytic modeling for health technology and policy development. His extensive research experience spans global health threats in Asia, emphasizing cost-effective interventions, health service assessment, and system strengthening, particularly in HIV/AIDS, substance use, mental health, and the COVID-19 pandemic.

Dr. Tran received a PhD in 2011 in Health Services Policy from the University of Alberta, Canada, followed by a 2013 postdoctoral fellowship at Johns Hopkins University and a 2023 Habilitation from Aix-Marseille University, France, Dr. Tran's expertise is internationally recognized. He's named a 2022 Highly Cited (Top 1%) Researcher by Clarivate, a runner-up for the 2022 APEC Research Prize on Healthy Women, Healthy Economies, and the recipient of the 2022 Rising Star of Science Award from Research.com.

Professor of Health Economics, Pontificia Universidad Javeriana, Bogotá, Colombia

2022 - Diego Rosselli, MD

Diego Rosselli first got involved in HEOR when he was appointed Director for Scientific and Technological Development in the Colombian Ministry of Health in 1993. He had been teaching basic neuroscience since the early eighties, but his academic position at Javeriana University, since 1997, represented a definitive career change. Many Latin American and Caribbean country has hosted at least one of his courses in the HEOR field. Both the Colombian ISPOR chapter, and the Javeriana ISPOR Student Chapter have been recognized as significant leaders in the region.

Associate Professor, Biostatistics, American University of Beirut, Beirut, Lebanon

2021 - Samer Kharroubi, PhD

Samer Kharroubi, PhD is currently a Tenured Associate Professor of Biostatistics and the Director of the Statistics Support Clinic in the Department of Nutrition and Food Sciences at the American University of Beirut since Spring 2016. He is also an Honorary Reader of Medical Statistics in the School of Health and Related Research at the University of Sheffield, UK. Further, he is a Chartered Statistician, which is a qualification administered by the Royal Statistical Society that recognizes his expertise as a practicing statistician.

His research and academic career started as Post-doctoral Research Associate in the Centre for Bayesian Statistics in Health Economics at Sheffield University in 2002, moving to the University of York (UK) as Lecturer in Statistics in 2006, then becoming a Senior Lecturer in 2011.

His research is in the theory and applications of “Bayesian Statistics”. On the methodological side, his main research area is in the computational aspects of Bayesian statistics and in Bayesian modelling generally. On the application side, his most significant research advances is in the application of Bayesian Statistics in Health Economics, focusing mainly on two areas: (1) the development of methods for estimating health utility algorithms in a Bayesian framework; and (2) the development of methods for the implementation of value of partial and sample information in decision analytic cost effectiveness models.